Mediation effect analysis of lipoprotein levels on BMI and cardiovascular outcomes in patients with heart failure
Open Access
- 12 October 2024
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-13
Abstract
Among heart failure patients with obesity, the prognosis is better than those with normal weight, a phenomenon known as the obesity paradox. However, it is unclear whether lipoprotein levels play a mediating role in the machine of the obesity paradox. The study included 1663 heart failure patients hospitalized from January, 2019 through August, 2022. Kaplan-Meier survival analysis and Log-rank tests were performed for three endpoints in order to determine cumulative event-free survival. We investigated the correlation between Body Max Index (BMI) and outcomes by multifactorial Cox models. Mediation analysis was applied to study the presence and magnitude of mediation effects of triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1 and apolipoprotein B, with the association between BMI and endpoints. In MACCEs, the median follow-up period was 679 days. In Cox model, compared with the underweight group, a high BMI level was significantly associated with lower all-cause mortality (HR=0.47, 95%CI 0.31~0.69, p<0.001, obese vs underweight), cardiovascular mortality (HR=0.46, 95%CI 0.30~0.73, p<0.001, obese vs underweight) and the incidence of MACCEs (HR=0.68, 95%CI 0.53~0.88, p=0.003, obese vs underweight). Mediation analysis revealed that TG was the strongest mediator between BMI and endpoints, with proportions of mediated effects of 6.6% (95%CI 2.2%~18.0%, p=0.0258, in all-cause death),7.0% (95%CI 2.3%~18.9%, p=0.0301, in cardiovascular death) and 10.2% (95%CI 3.3%~27.4%, p=0.0185, in MACCEs). There is an "obesity paradox" in patients with heart failure, and lipoprotein levels especially triglyceride mediate the association between BMI and cardiovascular outcomes.Keywords
This publication has 33 references indexed in Scilit:
- Long Term Changes in Health-Related Quality of Life for People with Heart Failure: The ECHOES StudyESC Heart Failure, 2022
- Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual dataClinical Research in Cardiology, 2021
- High-density lipoprotein-mediated cardioprotection in heart failureHeart Failure Reviews, 2020
- Obesity and heart failure with preserved ejection fraction: a paradox or something else?Heart Failure Reviews, 2019
- Obesity and the Obesity Paradox in Heart FailureProgress in Cardiovascular Diseases, 2018
- Obesity and Heart Failure: Focus on the Obesity ParadoxMayo Clinic Proceedings, 2017
- Role of HDL in Those with DiabetesCurrent Cardiology Reports, 2014
- HDL-cholesterol: Is it really good?Biochemical Pharmacology, 2008
- The endotoxin-lipoprotein hypothesisThe Lancet, 2000
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999